Primary prevention of rheumatic fever is theoretically feasible but practically almost impossible to achieve at the community level. It can be practised on an individual basis by identification of group-A beta hemolytic streptococcal sore throat and use of penicillin to eradicate the streptococci from the throat.
Because rheumatic fever can be serious, always call your provider if you suspect you or your child may have this condition. Common rheumatic fever symptoms include: Swollen, tender and red joints, especially the large joints such as the knees, ankles and elbows Chest pain or abnormal heartbeat.
People who have had heart inflammation during rheumatic fever might be advised to continue preventive antibiotic treatment for 10 years or longer.
Prognosis and Complications. Rheumatic heart disease is the most important long-term sequela of acute rheumatic fever due to its ability to cause disability or death. Untreated rheumatic fever increases a person’s risk of recurrent attacks and worsens prognosis.
Prevention. The only way to prevent rheumatic fever is to treat strep throat infections or scarlet fever promptly and completely with a full course of appropriate antibiotics.
It usually takes about 1 to 5 weeks after strep throat or scarlet fever for rheumatic fever to develop. Rheumatic fever is thought to be caused by a response of the body's defense system — the immune system.
Rheumatic heart disease describes a group of short-term (acute) and long-term (chronic) heart disorders that are caused by rheumatic fever. It usually occurs 10-20 years after the initial illness. Not everyone with rheumatic fever will go on to develop rheumatic heart disease.
Patients with persistent valvular disease should receive prophylaxis for 10 years after the last episode of acute rheumatic fever or until 40 years of age, whichever is longer.
Rheumatic fever doesn't have a cure, but treatments can manage the condition. Getting a precise diagnosis soon after symptoms show up can prevent the disease from causing permanent damage. Severe complications are rare. When they occur, they may affect the heart, joints, nervous system or skin.
It primarily affects children between the ages of 6 and 16, and develops after an infection with streptococcal bacteria, such as strep throat or scarlet fever. About 5% of those with untreated strep infection will develop rheumatic fever.
Rheumatic heart disease is preventable. Once a patient has been identified as having had rheumatic fever, it is important to prevent additional streptococcal infections as this could cause a further episode of rheumatic fever and additional damage to the heart valves.
Rheumatic heart disease disproportionately affects girls and women, whose risk of developing rheumatic heart disease is two times higher than in men and boys. Rheumatic heart disease is the leading cause of maternal cardiac complications in pregnancy.
Untreated or under-treated strep infections put a person at increased risk. Children who get repeated strep throat infections are at the most risk for rheumatic fever and rheumatic heart disease. A recent history of strep infection or rheumatic fever is key to the diagnosis of rheumatic heart disease.
Preventive treatment will likely continue through age 21 or until a child completes a minimum five-year course of treatment, whichever is longer. People who have had heart inflammation during rheumatic fever might need to continue preventive antibiotic treatment for 10 years or longer. Anti-inflammatory drugs.
Proper diagnosis and adequate antibiotic treatment of GAS infections can prevent acute rheumatic fever in most cases....Primary Prevention of Rheumatic Fever.AgentDosageEvidence rating*Amoxicillin50 mg per kg (maximum, 1 g) orally once daily for 10 days1B10 more rows•Feb 1, 2010
Secondary prophylaxis of acute rheumatic fever (ARF) and rheumatic heart disease (RHD) comprises long-term antibiotic therapy for individuals diagnosed with ARF or RHD, to prevent ARF recurrences triggered by recurrent group A streptococcal (GAS) infection, and therefore prevent the development of RHD or worsening of ...
vomiting. A wide variety of symptoms are associated with rheumatic fever. A person with the illness could experience a few, some, or most of the following symptoms. Symptoms usually appear two to four weeks after your child has a strep infection.
The most effective way to make sure your child doesn’t develop rheumatic fever is to start treating their strep throat infection within several days and to treat it thoroughly. This means ensuring your child completes all prescribed doses of medication. Practicing proper hygiene methods can help prevent strep throat:
This bacterium causes strep throat or, in a small percentage of people, scarlet fever. It’s an inflammatory disorder. Rheumatic fever causes the body to attack its own tissues. This reaction causes widespread inflammation throughout the body, which is the basis for all symptoms of rheumatic fever.
It’s a relatively serious illness that usually appears in children between the ages of 5 and 15. However, older children and adults have been known to contract the illness as well. It’s still common in places such as sub-Saharan Africa, south central Asia, ...
Rheumatic fever can cause long-term complications in certain situations. One of the most prevalent complications is rheumatic heart disease. Other heart conditions include: Aortic valve stenosis. This is a narrowing of the aortic valve in the heart. Aortic regurgitation.
If your child has a fever, they might require immediate care. Seek immediate medical care for your child in the following situations: For newborns to 6-week-old infants: more than a 100°F (37.8°C) temperature. For babies 6 weeks to 6 months old: a 101°F (38.3°C) or higher temperature.
Though aspirin use in children with certain illnesses has been associated with Reye’s Syndrome, the benefits of using it in treating rheumatic fever may outweigh the risks. Doctors may also prescribe a corticosteroid to reduce inflammation.
Secondary prevention of rheumatic fever requires antibiotic prophylaxis to reduce the likelihood of recurrent attacks in persons with a history of acute rheumatic fever. Because acute rheumatic fever frequently recurs with subsequent group A strep pharyngitis infections, long-term prophylaxis duration should be individually tailored but is usually indicated at least until age 21. Prophylaxis typically involves an intramuscular injection of benzathine penicillin every 4 weeks or oral penicillin V twice daily. Sulfadiazine or oral macrolides can be taken daily by individuals who are allergic to penicillin. 5,7 Current American Heart Association guidelines no longer recommend bacterial endocarditis prophylaxis for patients with rheumatic heart disease, unless the patient has a prosthetic valve. 8
Treatment. Patients with acute rheumatic fever should start on therapy for the symptomatic management of acute rheumatic fever, including salicylates and anti-inflammatory medicines to relieve inflammation and decrease fever, as well as management of cardiac failure.
Rheumatic heart disease is the most important long-term sequela of acute rheumatic fever due to its ability to cause disability or death. 1 Untreated rheumatic fever increases a person’s risk of recurrent attacks and worsens prognosis. Prognosis is related to the prevention of recurrent attacks, degree of cardiac valvular damage, ...
Streptococcal pharyngitis typically precedes the onset of acute rheumatic fever by 1 to 5 weeks. 1. S. pyogenes are gram-positive cocci that grow in chains (see figure 1). They exhibit β-hemolysis (complete hemolysis) when grown on blood agar plates.
Acute rheumatic fever is a delayed sequela of pharyngitis due to Streptococcus pyogenes, which are also called group A Streptococcus or group A strep. The etiology, clinical features, diagnosis and treatment options, prognosis and complications, and prevention are described below.
305,000 people die each year from rheumatic heart disease or its complications 11
There is no definitive diagnostic test for acute rheumatic fever. A clinical diagnosis of acute rheumatic fever should be made using the Jones Criteria. A 2015 revised version of the Jones Criteria endorsed by the American Heart Association now includes the addition of subclinical carditis as a major criteria and stratification of the major and minor criteria based upon epidemiologic risk (e.g., low, moderate, or high risk populations). 2
Primary prevention of acute rheumatic fever is accomplished by proper identification and adequate antibiotic treatment of group A β-hemolytic streptococcal (GAS) tonsillopharyngitis. Diagnosis of GAS pharyngitis is best accomplished by combining clinical judgment with diagnostic test results, the criterion standard of which is the throat culture. Penicillin (either oral penicillin V or injectable benzathine penicillin) is the treatment of choice, because it is cost-effective, has a narrow spectrum of activity, and has long-standing proven efficacy, and GAS resistant to penicillin have not been documented. For penicillin-allergic individuals, acceptable alternatives include a narrow-spectrum oral cephalosporin, oral clindamycin, or various oral macrolides or azalides. The individual who has had an attack of rheumatic fever is at very high risk of developing recurrences after subsequent GAS pharyngitis and needs continuous antimicrobial prophylaxis to prevent such recurrences (secondary prevention). The recommended duration of prophylaxis depends on the number of previous attacks, the time elapsed since the last attack, the risk of exposure to GAS infections, the age of the patient, and the presence or absence of cardiac involvement. Penicillin is again the agent of choice for secondary prophylaxis, but sulfadiazine or a macrolide or azalide are acceptable alternatives in penicillin-allergic individuals. This report updates the 1995 statement by the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee. It includes new recommendations for the diagnosis and treatment of GAS pharyngitis, as well as for the secondary prevention of rheumatic fever, and classifies the strength of the recommendations and level of evidence supporting them.
In general, prophylaxis should continue in these patients until the patient reaches 21 years of age or until 5 years has elapsed since the last rheumatic fever attack, whichever is longer (Class I, LOE C). In all situations, the decision to discontinue prophylaxis or to reinstate it should be made after discussion with the patient of the potential risks and benefits and careful consideration of the epidemiological risk factors enumerated above.
An injection of 1 200 000 U of this long-acting penicillin preparation every 4 weeks is the recommended regimen for secondary prevention in most circumstances in the United States (Class I, LOE A; Table 4 ). In populations in which the incidence of rheumatic fever is particularly high, the administration of benzathine penicillin G every 3 weeks is justified and recommended, because serum drug levels may fall below a protective level before the fourth week after administration of this dose of penicillin (Class I, LOE A). 69,70 In the United States, the administration of benzathine penicillin G every 3 weeks is recommended only for those who have recurrent acute rheumatic fever despite adherence to an every-4-week regimen (Class I, LOE C). Long-acting penicillin is of particular value in patients with a high risk of rheumatic fever recurrence, especially those with rheumatic heart disease, in whom the consequences of recurrence may be serious. The advantages of benzathine penicillin G must be weighed against the inconvenience to the patient and the pain of injection, which causes some individuals to discontinue prophylaxis. Although there has been concern about the risk of serious allergic reactions in patients receiving long-term intramuscular benzathine penicillin G prophylaxis for rheumatic fever, a large, international, prospective study determined that life-threatening allergic reactions are rare in these patients. 71 It has been demonstrated that the long-term benefits of such prophylaxis far outweigh the risk of serious allergic reactions.
GAS infections of the pharynx are the precipitating cause of rheumatic fever. During epidemics over a half century ago, as many as 3% of untreated acute streptococcal sore throats were followed by rheumatic fever; in endemic infections, the incidence of rheumatic fever is substantially less. 12 Appropriate antibiotic treatment of streptococcal pharyngitis prevents acute rheumatic fever in most cases. 13 Unfortunately, at least one third of episodes of acute rheumatic fever result from inapparent streptococcal infections. 14 In addition, some symptomatic patients do not seek medical care. In these instances, rheumatic fever is not preventable.
31 Therefore, a 24- to 48-hour delay to process the throat culture before antibiotic therapy is started does not increase the risk of rheumatic fever.
The individual who has had an attack of rheumatic fever is at very high risk of developing recurrences after subsequent GAS pharyngitis and needs continuous antimicrobial prophylaxis to prevent such recurrences (secondary prevention).
Primary prevention of rheumatic fever is theoretically feasible but practically almost impossible to achieve at the community level. It can be practised on an individual basis by identification of group-A beta hemolytic streptococcal sore throat and use of penicillin to eradicate the streptococci from the throat. Improving public awareness regarding danger of rheumatic fever from sore throat, identification of sore throat as being streptococcal and use of injectable penicillin to cure the streptococcal infection are the measures which are likely to be useful. Primary prevention is difficult to achieve because of the following factors. Only 3 – 20% of sore throats are streptococcal in origin. Of these only 0.3 – 3% result in rheumatic fever. If 10,000 sore throats are treated, of which 300 to 2000 will be streptococcal, it will prevent rheumatic fever in 1 to 6 children. Hence primary prevention is not a feasible option at the community level. Primary prevention is quite difficult to achieve. Oral penicillin may not be effective in preventing rheumatic fever. Rheumatic fever occurred in 15% to 48% children given oral penicillin for 10 days in a US epidemic. 400,000 units of procaine penicillin twice daily for 10 days may be needed.
Secondary prevention of rheumatic fever is the only viable preventive strategy. Options are:
Rheumatic fever with carditis, but no residual heart disease (no valvar disease – clinical or echocardiographic evidence): 10 years or 21 years, whichever is longer.
Primordial prevention is preventing the development of ‘risk factors’ in the community to prevent the disease in the population and thus protect individuals.
People who have had heart inflammation during rheumatic fever might be advised to continue preventive antibiotic treatment for 10 years or longer. Anti-inflammatory treatment. Your doctor will prescribe a pain reliever, such as aspirin or naproxen (Naprosyn, Naprelan, Anaprox DS), to reduce inflammation, fever and pain.
To test for rheumatic fever, your doctor is also likely to check for inflammation by measuring inflammatory markers in your child's blood, which include C-reactive protein and the erythrocyte sedimentation rate.
Treatments include: Antibiotics. Your child's doctor will prescribe penicillin or another antibiotic to eliminate remaining strep bacteria. After your child has completed the full antibiotic treatment, your doctor will begin another course of antibiotics to prevent recurrence of rheumatic fever. Preventive treatment will likely continue ...
Diagnosis. Although there's no single test for rheumatic fever, diagnosis is based on medical history, a physical exam and certain test results.
Take a family member or friend along, if possible, to help you remember the information you' re given .
Heart damage from rheumatic fever might not show up for years. When your child grows up, he or she needs to include the information in his or her medical history and get regular heart exams.
But it mostly affects young children and teenagers (ages 5 to 15). When people get rheumatic fever, it usually develops two to three weeks after an untreated strep throat or scarlet fever.
Common rheumatic fever symptoms include: Swollen, tender and red joints, especially the large joints such as the knees, ankles and elbows. Chest pain or abnormal heartbeat.
because providers effectively treat bacterial infections with antibiotics. Call your provider if your child has a sore throat for more than three days. Without treatment, rheumatic fever can cause serious health problems. Appointments 800.659.7822.
A rapid strep test can provide results within 10 minutes. A throat culture takes a few days to get results. However, rapid step tests sometimes give false-negative results (saying you don’t have strep when you really do).
Where you live: Most people with rheumatic fever live in places that have limited medical resources, such as resource-poor countries. Living in an area where it’s difficult to get medication or medical care may also put you at risk. Age: Rheumatic fever mostly affects children or teenagers between 5 and 15.
Some antibiotics are one injection (shot). Others you take by mouth for a week or more.
Rheumatic fever doesn’t have a cure, but treatments can manage the condition. Getting a precise diagnosis soon after symptoms show up can prevent the disease from causing permanent damage. Severe complications are rare. When they occur, they may affect the heart, joints, nervous system or skin.
Introduction. Acute rheumatic fever (ARF) is primarily the result of a bacterial infection with potentially serious consequences for the heart. ARF develops from contact with a specific bacterium called Group A Streptococcus (GAS). 1, 2 After exposure, the body generates antibodies to help destroy the bacteria.
Although not all sore throat leads to ARF, it is important that parents are educated to take their children to the doctor if they have symptoms of a sore throat ( Figure 2 ). The doctor can identify whether the sore throat is attributable to the GAS bacterium by taking a swab and then treating with antibiotics.
2. This disease has been almost eradicated in Western countries, but remains a major health problem in developing countries and among indigenous populations in wealthy countries.